SPAC Overview
$100M
IPO Size
Registration
Current Status
Timeline Progress
- Registration2025-12-19 Filed S1
- IPOWaiting on IPO
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
Brookline Capital Acquisition Corp II is a blank-check company seeking an initial business combination with an unidentified business. It may pursue any industry but intends to capitalize on its management team's abilities in healthcare and defense technology.
Investment Focus
Healthcare, Defense
Geographic Focus
North America, Europe
The terms and the filing trail behind Brookline Capital Acquisition Corp II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Samuel P. Wertheimer Ph.D.
Chairman of the Board of Directors, Chief Executive Officer, Director
Patrick Alexander Sturgeon
Chief Executive Officer, Chief Financial Officer, Director, President
Dimitre J. Genov
Chief Financial Officer, President, Vice President of Business Development
Hayden Edwards
Director, Vice President of Business Development
James L. Kempner
Director
Jordan Sun
Director
Thomas A. Vecchiolla
Director
Underwriters
Extended Team Information
Leadership and sponsor affiliate Brookline Capital Markets bring healthcare investment, capital-markets advisory and SPAC transaction experience.
Key Information
State of Incorporation
E9
SIC
6770
SPAC Ticker
N/A